Results of the mrc myelomatosis trials for patients entered since 1980
- 1 April 1988
- journal article
- clinical trial
- Published by Wiley in Hematological Oncology
- Vol. 6 (2), 145-158
- https://doi.org/10.1002/hon.2900060215
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Isoelectric points of urinary light chains in myelomatosis: analysis in relation to nephrotoxicity.Journal of Clinical Pathology, 1986
- The prognostic value of serum β 2 microglobulin compared with other presentation features in myelomatosisBritish Journal of Cancer, 1985
- Proximal renal tubular function in myelomatosis: observations in the fourth Medical Research Council trial.Journal of Clinical Pathology, 1984
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- HIGH-DOSE INTRAVENOUS MELPHALAN FOR PLASMA-CELL LEUKAEMIA AND MYELOMAThe Lancet, 1983
- Prednisone pulse therapy for refractory myelomaBlood, 1983
- Vindesine therapy in melphalan-resistant multiple myelomaEuropean Journal of Cancer (1965), 1981
- Report on the second myelomatosis trial after five years of follow-up.British Journal of Cancer, 1980
- A clinical staging system for multiple myeloma correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survivalCancer, 1975
- Myelomatosis: Comparison of Melphalan and Cyclophosphamide TherapyBMJ, 1971